Poly(ADP-ribose) polymerase-1 and its clinical applications in brain injury

Journal of Neuroscience Nursing

Volumn 39, Issue 5, 2007, Pages 278-284

  Barr, Taura L ^a   Conley, Yvette P ^b  

^a NATIONAL INSTITUTE OF NURSING RESEARCH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FREE RADICAL; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PARP1 PROTEIN, HUMAN; SIGNAL PEPTIDE; UNCLASSIFIED DRUG;

APOPTOSIS; BRAIN INJURY; CLINICAL TRIAL; DNA DAMAGE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; HEALTH SERVICE; HUMAN; IMMUNOLOGY; INTENSIVE CARE; METHODOLOGY; NURSE ATTITUDE; NURSING ASSESSMENT; OXIDATIVE STRESS; PHYSIOLOGY; PRACTICE GUIDELINE; REVIEW;

APOPTOSIS; BRAIN INJURIES; CLINICAL TRIALS AS TOPIC; CRITICAL CARE; DNA DAMAGE; FREE RADICALS; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NURSE'S ROLE; NURSING ASSESSMENT; OXIDATIVE STRESS; POLY(ADP-RIBOSE) POLYMERASES; PRACTICE GUIDELINES AS TOPIC;

EID: 38449096688     PISSN: 08880395     EISSN: None     Source Type: Journal    
DOI: 10.1097/01376517-200710000-00004     Document Type: Article

References (48)

1. Ang, B., Yap, E., Lim, J., Tan, W., Ng, P., Ng, I., et al. (2003). Poly (adenosine diphosphate-ribose) polymerase expression in human traumatic brain injury. Journal of Neurosurgery, 99, 125-130.
2. Bayir, H., Kagan, V. E., Borisenko, G. G., Tyurina, Y. Y., Janesko, K. L., Vagni, V. A., et al. (2005). Enhanced oxidative stress in iNOS-deficient mice after traumatic brain injury: Support for a neuroprotective role of iNOS. Journal of Cerebral Blood Flow and Metabolism, 25(6), 673-684.
3. Berger, N. A., Sims, J. L., Catino, D. M., & Berger, S. J. (1983). Poly (ADP-ribose) polymerase mediates the suicide response to massive DNA damage: Studies in normal and DNA-repair defective cells. Princess Takamatsu Symposia, 13, 219-226.
4. Besson, V. C., Croci, N., Boulu, R. G., Plotkine, M., & Marchand-Verrecchia, C. (2003). Deleterious poly(ADP-ribose) polymerase-1 pathway activation in traumatic brain injury in rat. Brain Research, 989(1), 58-66.
5. Brain Trauma Foundation. (2007). Guidelines for the management of severe traumatic brain injury. Journal of Neurotrauma, 24, S1: I-II.
6. Cazevieille, C., Muller, A., Meynier, F., & Bonne, C. (1993). Superoxide and nitric oxide cooperation in hypoxia/reoxygenation-induced neuron injury. Free Radical Biology and Medicine, 14(4), 389-395.
7. Chambon, P., Weill, J. D., & Mandel, P. (1963). Nicotinamide mononucleotide activation of a new DNA-dependent polyadenylic acid synthesizing nuclear enzyme. Biochemical and Biophysical Research Communications, 11(1), 39-43.
8. Chiarugi, A. (2005). Poly(ADP-ribosyl)ation and stroke. Pharmacological Research, 52(1), 15-24.
9. Cole, K., & Perez-Polo, R. (2002). Poly(ADP-ribose) polymerase inhibition prevents both apoptotic-like delayed neuronal death and necrosis after H2O2 injury. Journal of Neurochemistry, 82(1), 19-29.
10. Cole, K., & Perez-Polo, R. (2004). Neuronal trauma model: In search of Thanatos. International Journal of Developmental Neuroscience, 22(7), 485-496.
11. Cristofori, L., Tavazzi, B., Gambin, R., Vagnozzi, R., Signoretti, S., Amorini, A. M., et al. (2005). Biochemical analysis of the cerebrospinal fluid: Evidence for catastrophic energy failure and oxidative damage preceding brain death in severe head injury: A case report. Clinical Biochemistry, 38(1), 97-100.
12. Diefenbach, J., & Burkle, A. (2005). Introduction to poly (ADP-ribose) metabolism. Cellular and Molecular Life Sciences, 62, 721-730.
13. Fink, E., Lai, Y-C., Adelson, P. D., Kochanek, P. M., Janesko, K., Clark, R. S., et al. (2005). A novel method for quantification of poly(ADPribose) -modified proteins validated in cerebrospinal fluid from infants and children after traumatic brain injury. Presentation at Society of Critical Care Medicine 35th Critical Care Congress San Francisco, California, USA, January 7-11, 2006. Critical Care Medicine, 33(12 Abstract Supplement), Abstract No. 29.
14. Flamm, E., Demopoulos, H., Seligman, M., Poser, R., & Ransohoff, J. (1978). Free radicals in cerebral ischemia. Stroke, 9, 445-447.
15. Graziani, G., & Szabo, C. (2005). Clinical perspectives of PARP inhibitors. Pharmacological Research, 52, 109-118.
16. Ha, H., & Snyder, S. (2000). Poly(ADP-ribose) polymerase-1 in the nervous system. Neurobiology of Disease, 7, 225-239.
17. Hortobagyi, T., Gorlach, C., Benyo, Z., Lacza, Z., Hortobagyi, S., Wahl, M., et al. (2003). Inhibition of neuronal nitric oxide synthase-mediated activation of poly(ADP-ribose) polymerase in traumatic brain injury: Neuroprotection by 3-aminobenzamide. Neuroscience, 121(4), 983-990.
18. Ikeda, Y., Hokamura, K., Kawai, T., Ishiyama, J., Ishikawa, K., Anraku, T., et al. (2005). Neuroprotective effects of KCL-440, a new poly(ADP-ribose) polymerase inhibitor, in the rat middle cerebral artery occlusion model. Brain Research, 1060(1-2), 73-80.
19. Inci, S., Ozcan, O. E., & Kilinc, K. (1998). Time-level relationship for lipid peroxidation and the protective effect of alpha-tocopherol in experimental mild and severe brain injury. Neurosurgery, 43(2), 330-335.
20. Inotek Pharmaceuticals. (n.d.). INO-1001: Poly (ADP ribose) Polymerase Inhibitor. Retrieved March 7, 2007, from www.inotekcorp.com/content/ino-1001.asp.
21. Islekel, S., Islekel, H., Guner, G., & Ozdamar, N. (1999). Alterations in superoxide dismutase, glutathione peroxidase and catalase activities in experimental cerebral ischemia-reperfusion. Research in Experimental Medicine, 199(3), 167-176.
22. Kerr, M., Bender, C., & Monti, E. (1996). An introduction to oxygen free radicals. Heart and Lung, 25(3), 200-211.
23. Khan, T. A., Ruel, M., Bianchi, C., Voisine, P., Komjati, K., Szabo, C., et al. (2003). Poly(ADP-ribose) polymerase inhibition improves postischemic myocardial function after cardioplegia-cardiopulmonary bypass. Journal of the American College of Surgeons, 197(2), 270-277.
24. Koh, D., Dawson, T., & Dawson, V. (2005). Mediation of cell death by poly(ADP-ribose) polymerase-1. Pharmacological Research, 52, 5-14.
25. Kontos, H. (2001). Oxygen radicals in cerebral ischemia: The 2001 Willis Lecture. Stroke, 32, 2712-2716.
26. Langlois, J. A., Rutland-Brown W., & Thomas, K. E. (2004). Traumatic brain injury in the United States: Emergency department visits, hospitalizations, and deaths. Atlanta: Centers for Disease Control and Prevention National Center for Injury Prevention and Control.
27. Lindahl, T., Satoh, M., Poirier, G., & Klungland, A. (1995). Posttranslational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks. Trends in Biochemical Sciences, 20, 405-411.
28. Love, S., Barber, R., & Wilcock, G. K. (2000). Neuronal death in brain infarcts in man. Neuropathology and Applied Neurobiology, 26, 55-66.
29. MGI Pharma. (n.d.). PARP inhibitors. Retrieved March 7, 2007, from www.mgipharma.com/wt/page/parp.
30. Plummer, E. R., Middleton, M. R., Jones, C., Olsen, A., Hickson, I., McHugh, P., et al. (2005). Temozolomide pharmacodynamics in patients with metastatic melanoma: DNA damage and activity of repair enzymes O6-alkylguanine alkyltransferase and poly(ADP-ribose) polymerase-1. Clinical Cancer Research, 11(9), 3402-3409.
31. Reilly, P. (2001). Brain injury: The pathophysiology of the first hours. “Talk and Die revisited.” Journal of Clinical Neuroscience, 8(5), 398-403.
32. Rhodes, J. (2003). Actions of glucocorticoids and related molecules after traumatic brain injury. Current Opinion in Critical Care, 9, 86-91.
33. Roberts, I. (2000). Aminosteroids for acute traumatic brain injury. Cochrane Database of Systematic Reviews, 4, CD001527.
34. Ruppel, R., Clark, R. S., Bayir, H., Satchell, M. A., & Kochanek, P. M. (2002). Critical mechanisms of secondary damage after inflicted head injury in infants and children. Neurosurgery Clinics of North America, 13(2), 169-182.
35. Sies, H. (1985). Oxidative stress: Introductory remarks. London: Academic Press.
36. Smythies, J. (2000). Role of free radicals in the brain in health and disease in relation to synaptic plasticity. In G. Poli, E. Cadenas, & L. Packer (Eds.), Free radicals in brain pathophysiology (pp. 1-17). New York: Marcel Dekker.
37. Szabo, C. (2005). Roles of poly(ADP-ribose) polymerase activation in the pathogenesis of diabetes mellitus and its complications. Pharmacological Research, 52(1), 60-71.
38. Takahashi, K., Pieper, A. A., Croul, S. E., Zhang, J., Snyder, S. H., & Greenberg, J. H. (1999). Post-treatment with an inhibitor of poly(ADP-ribose) polymerase attenuates cerebral damage in focal ischemia. Brain Research, 829, 46-54.
39. Tavazzi, B., Signoretti, S., Lazzarino, G., Amorini, A. M., Delfini, R., Cimatti, M., et al. (2005). Cerebral oxidative stress and depression of energy metabolism correlate with severity of diffuse brain injury in rats. Neurosurgery, 56(3), 582-589.
40. Virag, L., & Szabo, C. (2002). The therapeutic potential of poly(ADPribose) polymerase inhibitors. Pharmacological Reviews, 54(3), 375-429.
41. Warner, D., Sheng, H., & Batinic-Haberle, I. (2004). Oxidants, antioxidants, and the ischemic brain. The Journal of Experimental Biology, 207, 3221-3231.
42. Watts, J. A., Grattan, R. M., Whitlow, B. S., & Kine, J. A. (2001). Activation of poly(ADP-ribose) polymerase in severe hemorrhagic shock and resuscitation. American Journal of Physiology. Gastrointestinal and Liver Physiology, 281, G498-G506.
43. Whalen, M. J., Clark, R. S., Dixon, C. E., Robichaud, P., Marion, D. W., Vagni, V., et al. (1999). Reduction of cognitive and motor deficits after traumatic brain injury in mice deficient in poly(ADP-ribose) polymerase. Journal of Cerebral Blood Flow and Metabolism, 19(8), 835-842.
44. Xiao, C. Y., Chen, M., Zsengeller, Z., & Szabo, C. (2004). Poly(ADPribose) polymerase contributes to the development of myocardial infarction in diabetic rats and regulates the nuclear translocation of apoptosis-inducing factor. Journal of Pharmacology and Experimental Therapeutics, 310(2), 498-504.
45. Xiong, Y., Shie, F. S., Zhang, J., Lee, C. P., & Ho, Y. S. (2005). Prevention of mitochondrial dysfunction in post-traumatic mouse brain by superoxide dismutase. Journal of Neurochemistry, 95(3), 732-744.
46. Ying, W., Wei, G., Wang, D., Wang, Q., Tang, X., Shi, J., et al. (2007). Intranasal administration with NAD+ profoundly decreases brain injury in a rat model of transient focal ischemia. Frontiers in Bioscience, 12, 2728-2734.
47. Yu, Y., Kim, J. B., Lee, K. W., Kim, S. Y., Han, P. L., & Lee, J. K. (2005). Inhibition of the cerebral ischemic injury by ethyl pyruvate with a wide therapeutic window. Stroke, 36(10), 2238-2243.
48. Zhang, J., Dawson, V., Dawson, T., & Snyder, S. (1994). Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science, 263, 687-689.